BIT 6.67% 3.2¢ biotron limited

Ann: BIT225 Phase 2 HIV Efficacy Trial Meets Primary Objectives, page-90

  1. 11,900 Posts.
    lightbulb Created with Sketch. 6045
    Never do ,,,, but understand your sentiment

    Biotechs and Baby Pharma always believe their science will speak for itself..... Science as a discipline does not value Marketing or Messaging ,, some Biotechs you would have to read articles in the Gazette or they believe an ASX announcement is Marketing , where as its actually the bare minimum ASX Regulatory Requirement..

    I'm as interested as most holders here to see if Management will meet announced deadlines... Best of Luck to all Holders NZT
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
(20min delay)
Last
3.2¢
Change
0.002(6.67%)
Mkt cap ! $28.87M
Open High Low Value Volume
3.1¢ 3.3¢ 3.1¢ $13.79K 424.2K

Buyers (Bids)

No. Vol. Price($)
1 329429 3.2¢
 

Sellers (Offers)

Price($) Vol. No.
3.4¢ 100000 1
View Market Depth
Last trade - 15.51pm 26/07/2024 (20 minute delay) ?
BIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.